Back to ALNY
Orbis Allan Gray Ltd ALNY Position History
Alnylam Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$973K
Q3 2026
Peak value
$642.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $642.7M |
| Q4 2025 | $824K |
| Q1 2026 | $933K |
| Q1 2026 | $440.7M |
| Q2 2026 | $849K |
| Q2 2026 | $597.4M |
| Q3 2026 | $596.4M |
| Q3 2026 | $973K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $973K | 3.9K | — | — |
| Q3 2026 | $596.4M | 2.42M | — | — |
| Q2 2026 | $597.4M | 1.98M | — | — |
| Q2 2026 | $849K | 2.8K | — | — |
| Q1 2026 | $440.7M | 1.33M | — | — |
| Q1 2026 | $933K | 2.8K | — | — |
| Q4 2025 | $824K | 2.1K | — | — |
| Q4 2025 | $642.7M | 1.62M | — | — |
Other funds holding ALNY
$5.8B
$5.7B
$4.9B
$4.8B
$4.2B
$3.4B